ATE325790T1 - Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung - Google Patents

Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung

Info

Publication number: ATE325790T1
Authority: AT; Austria
Prior art keywords: group; substituted; production; urea compounds; äwherein
Prior art date: 1999-10-05

Application number

AT00964649T

Other languages

English (en)

Inventor

Osamu Kurasawa

Shinichi Imamura

Shohei Hashiguchi

Osamu Nishimura

Naoyuki Kanzaki

Masanori Baba

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-05

Filing date

2000-10-04

Publication date

2006-06-15

2000-10-04 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE325790T1 publication Critical patent/ATE325790T1/de

Links

XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
208000030507 AIDS Diseases 0.000 abstract 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
102100035875 C-C chemokine receptor type 5 Human genes 0.000 abstract 1
101710149870 C-C chemokine receptor type 5 Proteins 0.000 abstract 1
208000031886 HIV Infections Diseases 0.000 abstract 1
208000037357 HIV infectious disease Diseases 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT00964649T 1999-10-05 2000-10-04 Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung ATE325790T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP28449599		1999-10-05

Publications (1)

Publication Number	Publication Date
ATE325790T1 true ATE325790T1 (de)	2006-06-15

Family

ID=17679268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00964649T ATE325790T1 (de)	1999-10-05	2000-10-04	Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung

Country Status (7)

Country	Link
US (1)	US6787650B1 (de)
EP (1)	EP1219605B1 (de)
AT (1)	ATE325790T1 (de)
AU (1)	AU7556000A (de)
CA (1)	CA2386387A1 (de)
DE (1)	DE60027908T2 (de)
WO (1)	WO2001025199A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2432527A1 (en) *	2000-12-22	2002-07-04	Takeda Chemical Industries, Ltd.	Medicinal compositions for oral use
FR2821356A1 (fr) *	2001-02-23	2002-08-30	Cerep	Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
GB0108099D0 (en) *	2001-03-30	2001-05-23	Hoffmann La Roche	Aminopiperidine derivatives
EP1500643A4 (de) *	2002-04-03	2007-03-28	Dainippon Sumitomo Pharma Co	Benzamidinderivate
CA2483253A1 (en) *	2002-04-24	2003-11-06	Takeda Pharmaceutical Company Limited	Use of compounds having ccr antagonism
JP2004107298A (ja) *	2002-09-20	2004-04-08	Takeda Chem Ind Ltd	ウレア化合物およびその用途
EP1708703A4 (de)	2003-12-11	2008-04-09	Anormed Inc	Chemokin-rezeptor-bindende verbindungen
US7498346B2 (en)	2003-12-11	2009-03-03	Genzyme Corporation	Chemokine receptor binding compounds
US20080108586A1 (en) *	2006-09-06	2008-05-08	Incyte Corporation	Combination therapy for human immunodeficiency virus infection
CN113214231B (zh) *	2020-01-21	2022-04-08	瀚远医药有限公司	5ht2a受体拮抗剂及其医疗应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3461120A (en) *	1965-09-27	1969-08-12	Sterling Drug Inc	N-((1-piperidyl)-lower-alkyl)-n-((3-,2-,and 1-indolyl)-lower-alkyl) amines
US4835157A (en)	1988-03-15	1989-05-30	Ortho Pharmaceutical Corporation	Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents
US5668151A (en)	1995-06-07	1997-09-16	Bristol-Myers Squibb Company	Dihydropyridine NPY antagonists: piperidine derivatives
JPH09255572A (ja)	1996-03-26	1997-09-30	Takeda Chem Ind Ltd	ケモカイン受容体拮抗剤
WO1999004794A1 (en)	1997-07-25	1999-02-04	Merck & Co., Inc.	Cyclic amine modulators of chemokine receptor activity
EP1140087A4 (de) *	1998-12-18	2002-04-03	Du Pont Pharm Co	N-ureidoalkyl-piperidine als modulatoren der chemokin-rezeptor-aktivität

2000
- 2000-10-04 AT AT00964649T patent/ATE325790T1/de not_active IP Right Cessation
- 2000-10-04 DE DE60027908T patent/DE60027908T2/de not_active Expired - Fee Related
- 2000-10-04 EP EP00964649A patent/EP1219605B1/de not_active Expired - Lifetime
- 2000-10-04 AU AU75560/00A patent/AU7556000A/en not_active Abandoned
- 2000-10-04 WO PCT/JP2000/006908 patent/WO2001025199A1/ja not_active Ceased
- 2000-10-04 US US10/089,961 patent/US6787650B1/en not_active Expired - Fee Related
- 2000-10-04 CA CA002386387A patent/CA2386387A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1219605B1 (de)	2006-05-10
WO2001025199A1 (en)	2001-04-12
DE60027908D1 (de)	2006-06-14
EP1219605A4 (de)	2002-10-30
AU7556000A (en)	2001-05-10
EP1219605A1 (de)	2002-07-03
CA2386387A1 (en)	2001-04-12
US6787650B1 (en)	2004-09-07
DE60027908T2 (de)	2007-05-10

Similar Documents

Publication	Publication Date	Title
ATE60761T1 (de)	1991-02-15	Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE126216T1 (de)	1995-08-15	Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
DK250386A (da)	1986-12-05	Fremgangsmaade til fremstilling af heterocycliske forbindelser
NO900991L (no)	1990-09-04	Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater
WO2006034833A1 (en)	2006-04-06	Cyclic diarly ureas suitable as tyrosine kinase inhibitors
DE68915225D1 (de)	1994-06-16	Benzazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
ATE79376T1 (de)	1992-08-15	Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
TW377352B (en)	1999-12-21	Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
KR880005093A (ko)	1988-06-28	5-알킬벤즈이미다졸, 그의 제조방법 및 이들을 함유하는 약제학적 조성물
DE50011034D1 (de)	2005-09-29	N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2336412A1 (en)	2000-01-13	Medicament for treatment of diabetes
ATE211468T1 (de)	2002-01-15	Neuraminsäuredervate, ihre herstellung und medizinische verwendung
ATE325790T1 (de)	2006-06-15	Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
ATE238285T1 (de)	2003-05-15	Pyrimidin-derivate
ATE69049T1 (de)	1991-11-15	Chinazolin-derivat, verfahren zu dessen herstellung und mittel zur behandlung von cerebraler disfunktion als aktiver inhaltsstoff.
ATE205209T1 (de)	2001-09-15	Chinolincarbonsäurederivate und ihre salze
TR200100083T2 (tr)	2001-06-21	2,5 İkameli benzol sülfonil ve tiyo üreler
ATE27455T1 (de)	1987-06-15	Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
ES2006165A6 (es)	1989-04-16	Procedimiento para la preparacion de derivados de 1,4-dihidropiridina y sus sales de adicion farmaceuticamente aceptables
DE60116655D1 (de)	2006-04-06	Carbamatderivate, verfahren zu deren herstellung und deren verwendung
DE3782235D1 (de)	1992-11-19	Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
WO2005025492A3 (en)	2005-08-11	Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease
DE3782229D1 (de)	1992-11-19	Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE69407227D1 (de)	1998-01-22	Die Verwendung von 2-Phenylmethylene-1-3'-(amino)-2-(hydroxy)-propoxy-imino-cyclohexane-Derivaten

Legal Events

Date	Code	Title	Description
2006-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties